EHealth Historical Income Statement

EHTH Stock

USD 5.00 0.05 1.01%

Historical analysis of EHealth income statement accounts such as Selling General Administrative of 46.8 M or Selling And Marketing Expenses of 182 M can show how well eHealth performed in making a profits. Evaluating EHealth income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of EHealth's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining eHealth latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether eHealth is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

About EHealth Income Statement Analysis

eHealth Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to EHealth shareholders. The income statement also shows EHealth investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

EHealth Income Statement Chart

As of now, EHealth's Gross Profit is increasing as compared to previous years. The EHealth's current Other Operating Expenses is estimated to increase to about 506 M, while Depreciation And Amortization is projected to decrease to under 18.9 M.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Operating Income Net Income From Continuing Ops

Total Revenue

Total revenue comprises all receipts eHealth generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of eHealth minus its cost of goods sold. It is profit before EHealth operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Operating Income

Operating Income is the amount of profit realized from eHealth operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of eHealth is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from EHealth's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into eHealth current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.As of now, EHealth's Gross Profit is increasing as compared to previous years. The EHealth's current Other Operating Expenses is estimated to increase to about 506 M, while Depreciation And Amortization is projected to decrease to under 18.9 M.

	2021	2022	2023	2024 (projected)
Gross Profit	536.2M	403.7M	451.1M	473.7M
Total Revenue	538.2M	405.4M	452.9M	475.5M

Gross Profit Total Revenue

EHealth income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Cost Of Revenue	Research Development	Income Tax Expense	Net Income From Continuing Ops	Non Operating Income Net Other	Non Recurring	Tax Provision	Reconciled Depreciation	Extraordinary Items	Net Interest Income
Depreciation And Amortization		0.2	0.66	0.79	0.64	0.64	0.72	-0.34	-0.98	-0.37	0.72	-0.5	0.16	-0.49	-0.26	0.83	-0.34	-0.41	-0.08	0.69	-0.52	0.67	0.16	-0.06
Interest Expense	0.2		0.35	0.42	0.48	0.48	0.44	0.19	-0.12	0.31	0.44	-0.02	-0.69	-0.04	-0.33	0.43	0.05	-0.04	-0.25	0.45	0.08	0.48	-0.09	-0.39
Selling General Administrative	0.66	0.35		0.83	0.8	0.8	0.82	-0.11	-0.62	-0.12	0.82	-0.3	-0.14	-0.3	-0.33	0.8	-0.19	-0.37	-0.18	0.73	-0.24	0.78	-0.14	-0.35
Selling And Marketing Expenses	0.79	0.42	0.83		0.95	0.95	0.99	-0.19	-0.75	-0.19	0.99	-0.4	-0.12	-0.4	-0.51	0.91	-0.22	-0.47	-0.28	0.81	-0.28	0.88	-0.33	-0.46
Total Revenue	0.64	0.48	0.8	0.95		1.0	0.97	0.09	-0.56	0.1	0.97	-0.11	-0.32	-0.12	-0.52	0.82	-0.04	-0.22	-0.17	0.86	0.02	0.78	-0.37	-0.44
Gross Profit	0.64	0.48	0.8	0.95	1.0		0.97	0.08	-0.56	0.1	0.97	-0.12	-0.32	-0.12	-0.53	0.82	-0.04	-0.23	-0.17	0.86	0.02	0.78	-0.37	-0.44
Other Operating Expenses	0.72	0.44	0.82	0.99	0.97	0.97		-0.16	-0.68	-0.14	1.0	-0.35	-0.15	-0.35	-0.56	0.89	-0.21	-0.46	-0.33	0.79	-0.21	0.89	-0.42	-0.54
Operating Income	-0.34	0.19	-0.11	-0.19	0.09	0.08	-0.16		0.51	0.95	-0.17	0.94	-0.7	0.91	0.21	-0.29	0.67	0.91	0.63	0.27	0.91	-0.45	0.19	0.4
Ebit	-0.98	-0.12	-0.62	-0.75	-0.56	-0.56	-0.68	0.51		0.54	-0.68	0.65	-0.3	0.64	0.25	-0.81	0.45	0.56	0.17	-0.59	0.67	-0.69	-0.12	0.1
Ebitda	-0.37	0.31	-0.12	-0.19	0.1	0.1	-0.14	0.95	0.54		-0.14	0.93	-0.72	0.9	0.1	-0.27	0.67	0.88	0.44	0.18	0.92	-0.38	0.11	0.24
Total Operating Expenses	0.72	0.44	0.82	0.99	0.97	0.97	1.0	-0.17	-0.68	-0.14		-0.36	-0.15	-0.36	-0.57	0.89	-0.22	-0.46	-0.33	0.79	-0.22	0.89	-0.42	-0.54
Income Before Tax	-0.5	-0.02	-0.3	-0.4	-0.11	-0.12	-0.35	0.94	0.65	0.93	-0.36		-0.48	0.98	0.31	-0.49	0.69	0.95	0.53	0.01	0.95	-0.59	0.14	0.38
Total Other Income Expense Net	0.16	-0.69	-0.14	-0.12	-0.32	-0.32	-0.15	-0.7	-0.3	-0.72	-0.15	-0.48		-0.45	0.22	-0.07	-0.4	-0.46	-0.38	-0.42	-0.56	0.03	-0.09	-0.1
Net Income	-0.49	-0.04	-0.3	-0.4	-0.12	-0.12	-0.35	0.91	0.64	0.9	-0.36	0.98	-0.45		0.2	-0.48	0.52	0.92	0.54	-0.02	0.91	-0.6	0.16	0.39
Cost Of Revenue	-0.26	-0.33	-0.33	-0.51	-0.52	-0.53	-0.56	0.21	0.25	0.1	-0.57	0.31	0.22	0.2		-0.55	0.53	0.43	0.21	-0.24	0.19	-0.5	0.23	0.37
Research Development	0.83	0.43	0.8	0.91	0.82	0.82	0.89	-0.29	-0.81	-0.27	0.89	-0.49	-0.07	-0.48	-0.55		-0.32	-0.52	-0.27	0.72	-0.42	0.85	-0.05	-0.35
Income Tax Expense	-0.34	0.05	-0.19	-0.22	-0.04	-0.04	-0.21	0.67	0.45	0.67	-0.22	0.69	-0.4	0.52	0.53	-0.32		0.7	0.28	0.09	0.73	-0.33	0.02	0.18
Net Income From Continuing Ops	-0.41	-0.04	-0.37	-0.47	-0.22	-0.23	-0.46	0.91	0.56	0.88	-0.46	0.95	-0.46	0.92	0.43	-0.52	0.7		0.66	0.01	0.87	-0.67	0.35	0.56
Non Operating Income Net Other	-0.08	-0.25	-0.18	-0.28	-0.17	-0.17	-0.33	0.63	0.17	0.44	-0.33	0.53	-0.38	0.54	0.21	-0.27	0.28	0.66		0.18	0.39	-0.63	0.65	0.91
Non Recurring	0.69	0.45	0.73	0.81	0.86	0.86	0.79	0.27	-0.59	0.18	0.79	0.01	-0.42	-0.02	-0.24	0.72	0.09	0.01	0.18		0.08	0.59	0.0	-0.06
Tax Provision	-0.52	0.08	-0.24	-0.28	0.02	0.02	-0.21	0.91	0.67	0.92	-0.22	0.95	-0.56	0.91	0.19	-0.42	0.73	0.87	0.39	0.08		-0.43	-0.08	0.16
Reconciled Depreciation	0.67	0.48	0.78	0.88	0.78	0.78	0.89	-0.45	-0.69	-0.38	0.89	-0.59	0.03	-0.6	-0.5	0.85	-0.33	-0.67	-0.63	0.59	-0.43		-0.43	-0.73
Extraordinary Items	0.16	-0.09	-0.14	-0.33	-0.37	-0.37	-0.42	0.19	-0.12	0.11	-0.42	0.14	-0.09	0.16	0.23	-0.05	0.02	0.35	0.65	0.0	-0.08	-0.43		0.82
Net Interest Income	-0.06	-0.39	-0.35	-0.46	-0.44	-0.44	-0.54	0.4	0.1	0.24	-0.54	0.38	-0.1	0.39	0.37	-0.35	0.18	0.56	0.91	-0.06	0.16	-0.73	0.82

Click cells to compare fundamentals

EHealth Account Relationship Matchups

EHealth income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	9.0M	529.5M	612.6M	488.5M	19.9M	18.9M
Interest Expense	46.1M	666K	845K	42.9M	11.0M	11.5M
Selling General Administrative	64.2M	76.5M	97.2M	71.8M	86.8M	46.8M
Selling And Marketing Expenses	150.2M	209.3M	262.6M	195.1M	173.3M	182.0M
Total Revenue	506.2M	582.8M	538.2M	405.4M	452.9M	475.5M
Gross Profit	503.5M	578.7M	536.2M	403.7M	451.1M	473.7M
Other Operating Expenses	400.7M	529.5M	612.6M	488.5M	481.9M	506.0M
Operating Income	129.6M	53.3M	(74.4M)	(83.1M)	(29.1M)	(27.6M)
Ebit	129.6M	(463.2M)	(717.8M)	(530.8M)	(29.1M)	(30.5M)
Ebitda	138.6M	66.3M	(105.2M)	(42.4M)	(9.2M)	(8.7M)
Total Operating Expenses	398.0M	525.4M	610.6M	486.8M	480.2M	504.2M
Income Before Tax	83.5M	54.0M	(124.9M)	(106.4M)	(30.6M)	(29.1M)
Total Other Income Expense Net	(46.1M)	666K	755K	(3.7M)	(1.5M)	(1.6M)
Net Income	66.9M	45.5M	(104.4M)	(88.7M)	(28.2M)	(26.8M)
Cost Of Revenue	2.7M	4.1M	2.0M	1.6M	1.8M	2.6M
Research Development	47.1M	65.2M	83.8M	78.8M	61.0M	37.0M
Income Tax Expense	16.6M	8.5M	(20.5M)	(17.7M)	(2.4M)	(2.3M)
Net Income Applicable To Common Shares	66.9M	45.5M	(122.9M)	(119.4M)	(107.5M)	(102.1M)
Net Income From Continuing Ops	66.9M	45.5M	(104.4M)	(88.7M)	(59.7M)	(56.7M)
Non Operating Income Net Other	755K	2.1M	666K	(3.7M)	(3.3M)	(3.1M)
Non Recurring	621K	2.0M	51.2M	19.6M	22.6M	12.9M
Tax Provision	16.6M	8.5M	(20.5M)	(17.7M)	571K	599.6K
Reconciled Depreciation	9.0M	12.9M	18.9M	21.1M	20.6M	14.9M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:

How To Invest In EHealth

Details

Is EHealth Stock a good investment?

Details

What is EHealth's Net Worth?

Details

Largest Insurance Brokers Companies

View

Largest Financial Services Companies

View

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.108

Earnings Share

(2.62)

Revenue Per Share

16.016

Quarterly Revenue Growth

(0.1)

Return On Assets

(0.01)

The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EHealth Historical Income Statement

About EHealth Income Statement Analysis

EHealth Income Statement Chart

Total Revenue

Gross Profit

Operating Income

EHealth income statement Correlations

EHealth Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EHealth income statement Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Other Operating Expenses	+ 0.99	Selling And Marketing Expenses
Total Operating Expenses	+ 0.99	Selling And Marketing Expenses
Net Income	+ 0.98	Income Before Tax
Other Operating Expenses	+ 0.97	Total Revenue

Ebit	- 0.98	Depreciation And Amortization
Research Development	- 0.81	Ebit
Ebit	- 0.75	Selling And Marketing Expenses
Net Interest Income	- 0.73	Reconciled Depreciation
Total Other Income Expense Net	- 0.72	Ebitda
Total Other Income Expense Net	- 0.7	Operating Income